Answer to yesterday’s quiz: What was the rate of - TopicsExpress



          

Answer to yesterday’s quiz: What was the rate of progression-free survival at 24 weeks in this study? A. 56%. B. 66%. C. 76%. D. 86%. The answer is D. In heavily pretreated patients with relapsed or refractory Hodgkin’s lymphoma, the majority of whom had had a relapse after autologous stem-cell transplantation and brentuximab vedotin treatment, the use of nivolumab was associated with an overall response rate of 87% and a rate of progression-free survival of 86% at 24 weeks. nej.md/1yRWpVq
Posted on: Tue, 27 Jan 2015 14:00:01 +0000

Trending Topics



Recently Viewed Topics




© 2015